SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS

Clinical trials for SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS explained in plain language.

Never miss a new study

Get alerted when new SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS trials appear

Sign up with your email to follow new studies for SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Multi-Year trial tests Long-Term safety of promising lupus skin treatment

Disease control ENROLLING_BY_INVITATION

This study aims to learn about the long-term safety and effectiveness of an investigational drug called litifilimab for adults with cutaneous lupus, a condition causing skin rashes and lesions. It will follow about 322 participants who previously benefited from the drug in an ear…

Matched conditions: SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS

Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS

Get alerted when new SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS trials appear

Multi-Year trial tests Long-Term safety of promising lupus skin treatment